MolNFT v1 · #81025 · protein
Crystal structure of human survivin K62A mutant
3UEG · Baculoviral iap repeat-containing protein 5: “Crystal structure of human survivin K62A mutant”. X-ray diffraction, 1 ligand (ZN), 2 pockets (best druggability 0.53). MolNFT v1 #81025 on GenesisL1: 3D structure, binding sites and…
- PDB
- 3UEG
- Type
- protein
- Length
- 275 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Baculoviral iap repeat-containing protein 5
- UniProt
- O15392
- Ligands
- ZN
- Pockets
- 2 · best druggability 0.53
Structure
x-ray diffraction · 2 distinct chains · 56% helix, 7% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Baculoviral iap repeat-containing protein 5 | protein | 137 | 56% helix, 7% strand | O15392 |
| B | Baculoviral iap repeat-containing protein 5 | protein | 138 | 56% helix, 7% strand | O15392 |
Ligands and binding sites
- ZN · Zinc ion · metal · 2 copies · chains A, B
- EDO · 1,2-ethanediol · additive · chains A
- PG4 · Tetraethylene glycol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 113 | 0.53 | 0.82 | 20 | empty |
| 2 | 119 | 0.53 | 0.81 | 20 | empty |
Interfaces
1 interface between chains.
- A–B · 552 Ų buried · 6 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O15392
- Elsewhere: RCSB PDB 3UEG · PDBe 3UEG · UniProt O15392
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.